主治醫師：薛純

論文及學術著作

• Liao CT, Hsieh CH, Fan WL, Ng SH, Cheng NM, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Lin CH, Tsao CK, Kang CJ, Fang TJ, Huang SF, Chang KP, Lee LA, Fang KH, Wang YC, Yang LY, Yen TC*. A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2020 Jan; 47(1):84-93.
• Chuang WY*, Chang SH, Yu WH, Yang CK, Yeh CJ, Ueng SH, Liu YJ, Chen TD, Chen KH, Hsieh YY, Hsia Y, Wang TH, Hsueh C, Kuo CF, Yeh CY. Successful Identification of Nasopharyngeal Carcinoma in Nasopharyngeal Biopsies Using Deep Learning. Cancers (Basel). 2020 Feb 22; 12(2):507. doi: 10.3390/cancers12020507.PMID: 32098314 Free PMC article.
• Tsai CY*, Chen ST, Hsueh C, Lin YS, Lin JD*. Long-term therapeutic outcomes of papillary thyroid carcinoma with concomitant hyperparathyroidism: A single center case-control study. Biomed J. 2020 Feb; 43(1):53-61.
• Chen YT*, Ou Yang WT, Juang HH, Chen CL*, Chen HW, Tsui KH, Chang YH, Tsai CH, Hsueh C, Liao WC. Proteomic characterization of arsenic and cadmium exposure in bladder cells. Rapid Commun Mass Spectrom. 2020 Apr; 34 Suppl 1:e8578. doi: 10.1002/rcm.8578. Epub 2020 Feb 8.PMID: 31499585
• Chuang WY, Chang ST, Yuan CT, Chang GJ, Chang H, Yeh CJ, Ueng SH, Kao HW, Wang TH, Wan YL, Shih LY, Chuang SS, Hsueh C*. Identification of CD5/Cyclin D1 double-negative pleomorphic mantle cell lymphoma: A clinicopathologic, genetic, and gene expression study. Am J Surg Pathol. 2020 Feb; 44(2):232-240. (Corresponding author*)
• Lin CY, Fan KH, Lee LY, Hsueh C, Yang LY, Ng SH, Wang HM, Hsieh CH, Lin CH, Tsao CK, Kang CJ, Fang TJ, Lee LA, Huang SF, Chang KP, Yen TC, Tay ZY, Wen YW, Lee SR, Liao CT*. Precision adjuvant therapy based on detailed pathologic risk factors for resected oral cavity squamous cell carcinoma: Long-term outcome comparison of CGMH and NCCN guidelines. Int J Radiat Oncol Biol Phys. 2020 Apr 1; 106(5):916-925.
• Wang TH*, Wu CC, Huang KY, Chuang WY, Hsueh C, Li HJ, Chen CY. Profiling of subcellular EGFR interactome reveals hnRNP A3 modulates nuclear EGFR localization. Oncogenesis. 2020 Apr 22; 9(4):40. doi: 10.1038/s41389-020-0225-0.PMID: 32321917 Free PMC article.
• Chen CY, Fang JY, Chen CC, Chuang WY, Leu YL, Ueng SH, Wei LS, Cheng SF, Hsueh C, Wang TH*. 2-O-Methylmagnolol, a magnolol derivative, suppresses hepatocellular carcinoma progression via inhibiting class I histone deacetylase expression. Front Oncol. 2020 Aug 11; 10:1319. doi: 10.3389/fonc.2020.01319. eCollection 2020.
• Yeh PJ, Chen CC, Chao HC, Lai JY, Hsueh C, Wang CJ, Lai MW*. High initial bowel resection rate and very-early-onset inflammatory bowel disease - A challenge in a low-prevalence area. J Formos Med Assoc. 2021 Jan; 120(1 Pt 3):720-727.
• Liao CT, Hsieh CH, Fan WL, Ng SH, Cheng NM, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Lin CH, Tsao CK, Kang CJ, Fang TJ, Huang SF, Chang KP, Lee LA, Fang KH, Wang YC, Yang LY, Yen TC*. A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2020 Jan; 47(1):84-93.
• Yeh PJ, Chen CC, Chao HC, Lai JY, Hsueh C, Wang CJ, Lai MW*. High initial bowel resection rate and very-early-onset inflammatory bowel disease - A challenge in a low-prevalence area. J Formos Med Assoc. 2021 Jan; 120(1 Pt 3):720-727.
• Lu YL, Chen ST, Ho TY, Chan WH, Wong RJ, Hsueh C, Lin SF*. Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study. World J Clin Cases. 2021 Jan 6; 9(1):71-80.
• Chen SH*, Du CJ, Lai JY, Chang TY, Yang CP, Hung IJ, Jaing TH, Ming YC, Hsueh C. Malignant sacrococcygeal germ cell tumors in children in Taiwan: A retrospective single-center case series. Medicine (Baltimore). 2021 Jan 29; 100(4):e24323. doi: 10.1097/MD.0000000000024323
• Chen CY, Chen CC, Chuang WY, Leu YL, Ueng SH, Hsueh C, Yeh CT*, Wang TH*. Hydroxygenkwanin inhibits class I HDAC expression and synergistically enhances the antitumor activity of sorafenib in liver cancer cells. Front Oncol. 2020 Feb 25;10:216.
• Lin CY, Fan KH, Lee LY, Hsueh C, Yang LY, Ng SH, Wang HM, Hsieh CH, Lin CH, Tsao CK, Kang CJ, Fang TJ, Lee LA, Huang SF, Chang KP, Yen TC, Tay ZY, Wen YW, Lee SR, Liao CT*. Precision adjuvant therapy based on detailed pathologic risk factors for resected oral cavity squamous cell carcinoma: Long-term outcome comparison of CGMH and NCCN guidelines. Int J Radiat Oncol Biol Phys. 2020 Apr 1; 106(5):916-925.
• Chen JC*, Hsueh C. Apple-core lesion of the terminal ileum in a child with chronic constipation.. Arch Dis Child. 2021 Dec;106(12):1237. doi: 10.1136/archdischild-2021-321935. Epub 2021 Apr 27.
• Tsai CY, Lee SR, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Hsieh CH, Ng SH, Yeh CH, Lin CH, Tsao CK, Fang TJ, Huang SF, Lee LA, Kang CJ, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Cheng NM, Wen YW, Liao CT*. Clinical outcomes of Taiwanese patients with resected squamous cell carcinoma of the upper and lower gum. Oral Oncol. 2021 Jul; 118:105334. doi: 10.1016/j.oraloncology.2021.105334. Epub 2021 May
• Kang CJ, Tsai CY, Lee LY, Lin CY, Yang LY, Cheng NM, Hsueh C, Fan KH, Wang HM, Hsieh CH, Ng SH, Yeh CH, Lin CH, Tsao CK, Fang TJ, Huang SF, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT*. Prognostic stratification of patients with AJCC 2018 pStage IVB oral cavity cancer: Should pT4b and pN3 disease be reclassified? Oral Oncol. 2021 Aug; 119:105371. doi: 10.1016/j.oraloncology.2021.105371. Epub 2021 Jun 24.
• Yu CC*, Cheung YC, Hsueh C, Chen SC. Predictors of sentinel lymph node metastasis in postoperatively upgraded invasive breast carcinoma patients. Cancers (Basel). 2021 Aug 14; 13(16):4099. doi: 10.3390/cancers13164099.
• Chuang WY, Chen CC, Yu WH, Yeh CJ, Chang SH, Ueng SH, Wang TH, Hsueh C, Kuo CF, Yeh CY*. Identification of nodal micrometastasis in colorectal cancer using deep learning on annotation-free whole-slide images. Mod Pathol. 2021 Oct; 34(10):1901-1911.
• Lee LY, Lin CY, Cheng NM, Tsai CY, Hsueh C, Fan KH, Wang HM, Hsieh CH, Ng SH, Yeh CH, Lin CH, Tsao CK, Fang TJ, Huang SF, Lee LA, Kang CJ, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT*. Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer--Comparison with pathological risk factors according to the NCCN guidelines. Cancer Med. 2021 Oct; 10(19):6627-41.
• Lin CY, Lee LY, Cheng NM, Lee SR, Tsai CY, Hsueh C, Fan KH, Wang HM, Hsieh CH, Ng SH, Yeh CH, Lin CH, Tsao CK, Fang TJ, Huang SF, Lee LA, Kang CJ, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT*. cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinoma. Cancer Med. 2021 Oct; 10(20):6947-6958.
• Cheng NM, Kang CJ, Tsai CY, Lee LY, Lin CY, Hsueh C, Fan KH, Wang HM, Hsieh CH, Ng SH, Yeh CH, Lin CH, Tsao CK, Fang TJ, Huang SF, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT*. Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastases. Oral Oncol. 2021 Dec; 123:105593. doi: 10.1016/j.oraloncology.2021.105593. Epub 2021 Nov 9.
• Kang CJ, Wen YW, Lee SR, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Hsieh CH, Ng SH, Yeh CH, Lin CH, Tsao CK, Fang TJ, Huang SF, Lee LA, Fang KH, Yen TC*, Cheng NM, Tsai TY, Tai SF, Tsai CY. Surgical margins status and prognosis after resection of oral cavity squamous cell carcinoma: Results from a Taiwanese nationwide registry-based study. Cancers (Basel). 2021 Dec 21; 14(1):15.
• Hsu YC, Hsueh C, Lin WN, Tsai TY, Hung SY, Lu YA*. Carcinoma showing thymus-like differentiation (CASTLE) with synchronous papillary thyroid carcinoma: A case report and review. Ear Nose Throat J. 2024 Jul; 103(7):NP411-NP421. doi: 10.1177/01455613211060167. Epub 2021 Dec 6.
• Kang CJ, Wen YW, Lee SR, Ng SH, Lee LA, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Hsieh CH, Yeh CH, Tsai CY, Lin CH, Tsao CK, Fang TJ, Huang SF, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Cheng NM, Liao CT*. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study. Oral Oncol. 2022 Mar;126:105750. doi: 10.1016/j.oraloncology.2022.105750. Epub 2022 Feb 2.
• Yu WJ, Chao HC*, Hsueh C. Gastric outlet obstruction resulting from Crohn's disease. Pediatr Neonatol. 2022 May; 63(3):308-10.
• Chiu CC, Jaing TH*, Lai JY, Chen SH, Chang TY, Hsueh C, Wen YC, Tsay PK. Malignant testicular tumors in children: A single institution's 12-year experience. Medicine (Baltimore). 2022 Jul 22; 101(29):e29735. doi: 10.1097/MD.0000000000029735.
• Sun JH, Li YR, Chang KH, Liou MJ, Lin SF, Tsai SS, Yu MC, Hsueh C, Chen ST*. Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan. Biomed J. 2022 Dec;45(6):923-930.
• Chuang WY, Yu WH, Lee YC, Zhang QY, Chang H, Shih LY, Yeh CJ, Lin SM, Chang SH, Ueng SH, Wang TH, Hsueh C, Kuo CF, Chuang SS*, Yeh CY*. Deep learning-based nuclear morphometry reveals an independent prognostic factor in mantle cell lymphoma. Am J Pathol. 2022 Dec; 192(12):1763-78.
• Sun JH, Li YR, Chang KH, Liou MJ, Lin SF, Tsai SS, Yu MC, Hsueh C, Chen ST*. Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan. Biomed J. 2022 Dec; 45(6):923-930.
• Tsai CY, Wen YW, Lee SR, Ng SH, Kang CJ, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Hsieh CH, Yeh CH, Lin CH, Tsao CK, Fang TJ, Huang SF, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Cheng NM, Liao CT*. Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study. BMC Cancer. 2023 Feb 7; 23(1):126. doi: 10.1186/s12885-023-10602-1.
• Wang TH*, Huang KY, Chen CC, Chang YH, Chen HY, Hsueh C, Liu YT, Yang SC, Yang PC, Chen CY. PM2.5 promotes lung cancer progression through activation of the AhR-TMPRSS2-IL18 pathway. EMBO Mol Med. 2023 Jun 7; 15(6):e17014. doi: 10.15252/emmm.202217014. Epub 2023 Mar 28.
• Chuang WY, Chang H, Shih LY, Lin TC, Yeh CJ, Ueng SH, Kuo MC, Kao HW, Liu H, Chang ST, Lee CL, Huang KP, Wang TH, Wan YL, Yu JS, Hsueh C, Chuang SS*. Identification of CD5/SOX11 double-negative pleomorphic mantle cell lymphoma. Virchows Arch. 2024 Aug; 485(2):323-334